Profile data is unavailable for this security.
About the company
Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.
- Revenue in CAD (TTM)0.00
- Net income in CAD-2.71m
- Incorporated2011
- Employees8.00
- LocationTelo Genomics CorpMars Centre, 101 College St Suite 200TORONTO M5G 1L7CanadaCAN
- Phone+1 (416) 673-8487
- Fax+1 (204) 582-0922
- Websitehttps://www.telodx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| StageZero Life Sciences Ltd | -100.00bn | -100.00bn | 4.92m | 40.00 | -- | -- | -- | -- | -- | -- | -- | -0.1212 | -- | -- | -- | -- | -- | -135.76 | -- | -- | -- | -2.74 | -- | -246.92 | 0.0204 | -- | -- | -- | -25.12 | 55.93 | -52.53 | -- | -- | -- |
| Quest PharmaTech Inc | 0.00 | 13.58m | 5.07m | 0.00 | 0.3737 | 0.2205 | 0.3737 | -- | 0.0803 | 0.0803 | 0.00 | 0.136 | 0.00 | -- | -- | -- | 53.30 | 7.62 | 55.60 | 8.45 | -- | -- | -- | -- | -- | -- | 0.0417 | 0.00 | -- | -- | 95.35 | -- | -- | -- |
| XORTX Therapeutics Inc | 0.00 | -2.07m | 5.43m | 3.00 | -- | 1.44 | -- | -- | -0.6985 | -0.6985 | 0.00 | 1.30 | 0.00 | -- | -- | -- | -23.54 | -35.42 | -29.36 | -40.37 | -- | -- | -- | -- | -- | -- | 0.03 | -- | -- | -- | 72.04 | -- | 7.91 | -- |
| Innovotech Inc | 1.23m | -364.50k | 6.13m | 16.00 | -- | 8.02 | -- | 4.99 | -0.0094 | -0.0094 | 0.0315 | 0.0187 | 1.10 | 5.81 | 5.84 | -- | -32.59 | 2.90 | -37.99 | 3.56 | 68.63 | 71.56 | -29.67 | 2.19 | 2.17 | -- | 0.1115 | -- | 5.05 | 7.42 | -15.43 | -- | 35.69 | -- |
| Principal Technologies Inc | 618.64k | -1.90m | 6.27m | -- | -- | 10.33 | -- | 10.13 | -0.0766 | -0.0766 | 0.0246 | 0.0165 | 0.5664 | -- | 2.92 | -- | -170.72 | -- | -445.11 | -- | 21.57 | -- | -301.45 | -- | -- | -31.95 | 0.0959 | -- | 25.43 | -- | 23.53 | -- | -- | -- |
| Marvel Biosciences Corp | 0.00 | -2.10m | 6.27m | -- | -- | -- | -- | -- | -0.0529 | -0.0529 | 0.00 | -0.0693 | 0.00 | -- | -- | -- | -268.48 | -- | -- | -- | -- | -- | -- | -- | -- | -14.33 | -- | -- | -- | -- | 10.29 | -- | -- | -- |
| Rakovina Therapeutics Inc | 0.00 | -2.94m | 7.22m | -- | -- | 1.77 | -- | -- | -0.0419 | -0.0419 | 0.00 | 0.0452 | 0.00 | -- | -- | -- | -46.65 | -- | -51.51 | -- | -- | -- | -- | -- | -- | -13.01 | 0.2652 | -- | -- | -- | 6.39 | -- | -- | -- |
| Medicure Inc | 20.93m | -2.63m | 9.18m | 25.00 | -- | 0.47 | -- | 0.4388 | -0.2529 | -0.2529 | 1.94 | 1.87 | 0.7288 | 2.28 | 4.38 | 837,280.00 | -9.16 | -13.42 | -12.73 | -18.28 | 61.41 | 61.87 | -12.56 | -27.38 | 1.42 | -- | 0.0202 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
| Telo Genomics Corp | 0.00 | -2.71m | 9.32m | 8.00 | -- | 15.79 | -- | -- | -0.038 | -0.038 | 0.00 | 0.0079 | 0.00 | -- | -- | -- | -139.44 | -87.48 | -167.71 | -103.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.82 | -- | -- | -- |
| Hemostemix Inc | 0.00 | -1.94m | 9.92m | -- | -- | -- | -- | -- | -0.0214 | -0.0214 | 0.00 | -0.0959 | 0.00 | -- | -- | -- | -705.31 | -599.98 | -- | -- | -- | -- | -- | -- | -- | -1.74 | -- | -- | -- | -- | 52.21 | -- | -- | -- |
